Vyera Pharmaceuticals, formerly known as Turing Pharmaceuticals, does not have to pay Impax Laboratories Inc $43 million in a dispute stemming from Turing founder Martin Shkreli’s decision to boost by 5,000 percent the price of a drug Turing bought from Impax, a U.S.judge ruled on Friday. U.S....CONTINUE READING >>>
Company founded by ‘Pharma Bro’ Martin Shkreli off the hook in $43 million lawsuit: judge
